Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 0 | 0 | 0 | 1 | 6 |
| Cost of Goods | N/A | N/A | 0 | 1 | 4 |
| Gross Profit | N/A | N/A | 0 | 0 | 2 |
| Operating Expenses | 12,326 | 10,344 | 10,300 | 7,211 | 5,704 |
| Operating Income | -12,326 | -10,344 | -10,300 | -7,210 | -5,698 |
| Interest Expense | 0 | 0 | 10 | 1,900 | 5,320 |
| Other Income | 4 | 74 | 310 | 240 | -742 |
| Pre-tax Income | -12,322 | -10,270 | -10,000 | -8,870 | -11,760 |
| Net Income Continuous | -12,322 | -10,270 | -10,006 | -8,871 | -11,039 |
| Net Income | $-12,322 | $-10,270 | $-10,000 | $-8,870 | $-11,760 |
| EPS Basic Total Ops | -0.21 | -0.20 | -0.22 | -0.23 | -0.62 |
| EPS Basic Continuous Ops | -0.21 | -0.20 | -0.22 | -0.23 | -0.59 |
| EPS Diluted Total Ops | -0.21 | -0.20 | -0.22 | -0.23 | -0.62 |
| EPS Diluted Continuous Ops | -0.21 | -0.20 | -0.22 | -0.23 | -0.59 |
| EBITDA(a) | $-11,646 | $-9,663 | $-9,540 | $-4,690 | $-778 |